AgeX Therapeutics Inc. (AGE) Fundamentals

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop innovative medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1 and AGEX-BAT1. And iTR drug-based therapeutic candidates in development are AGEX-iTR1547 and Renelon.
SHARE INFORMATION
Market Cap$ 96,332,800
Shares Outstanding37,630,000
Float37,556,002
Percent Float99.8%
Short Interest1,103,332.00
Short Percent Float2.9%
Short Interest Ratio13.15
Short Interest Date2019-08-30
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,376,000
Latest Fiscal EPS$ -0.21
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions125
Institutional Holdings Date2019-08-31
Institutional Bought Previous 3 Months1,114,018
Institutional Holdings Percent21.8%
Institutional Sold Previous 3 Months285,910
Insider Holdings Date2019-08-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.2
Insider Sold Previous 3 Months-
Insider Shares Owned73,998
TRADING INFO
52 Week High$ 5.95
52 Week Low$ 1.13
52 Week High Change$ 0.00
21 Day Moving Average$ 2.6705
21 Day Extended Moving Average$ 2.6693
50 Day Moving Average$ 2.7472
50 Day Extended Moving Average$ 2.8115
200 Day Moving Average$ 3.6403
200 Day Extended Moving Average$ 3.2572
10 Day Average Volume66,257
20 Day Average Volume80,293
30 Day Average Volume82,711
50 Day Average Volume80,340
Alpha-0.082654
Beta4.4302
Standard Deviation0.255802
R20.890256
7 Day Price Change$ -0.04
7 Day Percent Change-1.54%
21 Day Price Change$ -0.10
21 Day Percent Change-3.76%
30 Day Price Change$ -0.41
30 Day Percent Change-13.8%
Month to Date Price Change$ -0.16
Month to Date Percent Change-5.88%
Quarter to Date Price Change$ -1.11
Quarter to Date Percent Change-30.25%
180 Day Price Change$ -1.63
180 Day Percent Change-38.9%
200 Day Price Change$ -2.29
200 Day Percent Change-47.22%
Year to Date Price Change$ -0.43
Year to Date Percent Change-14.38%

AgeX Therapeutics Inc. (AGE) Key Ratios

PROFITABILITY
EBIT Margin-829.8%
EBITDA Margin-782.2%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin80.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,379,000
Revenue Per Share$ 0.0366
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book23.00
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio2.50
Leverage Ratio1.40
Quick Ratio2.30
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 94,158,200
Price to Sales69.857
Price to Free Cash-9.80
PE High Last 5 Years0.00
Price To Book14.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book23.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover8.80
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-112.69
Return on Equity-171.32
Return on Capital-156.73

AgeX Therapeutics Inc. (AGE) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorOUM & Co. LLP
CEOMichael D. West
Emplyoees12
Last AuditUQ
CIK0001708599
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1010 Atlantic Avenue
Suite 102
Alameda, CA 94501
Websitehttps://www.agexinc.com
Facsimile+1 510 871-4154
Telephone+1 510 871-4190
Email-
Your Recent History
NYSE
AGE
A G Edward..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221205 15:04:57